South Korea Hepatitis B Infection Market to 2032
Overview
The South Korea Hepatitis B Infection Market is expected to reach a 397.57 USD Million by 2032 and is projected to grow at a CAGR of 5.55% from 2025 to 2032.
Revenue, 2024 (USD Million)
272.34
Forecast, 2032 (USD Million)
397.57
CAGR, 2024 - 2032
5.55%
Report Coverage
South Korea
South Korea Hepatitis B Infection Market 2018-2032 USD Million
South Korea Hepatitis B Infection Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 272.34 USD Million
- Projected Market Size (2032): 397.57 USD Million
- CAGR (2025-2032): 5.55%
Key Findings of South Korea Hepatitis B Infection Market
- The South Korea Hepatitis B Infection Market was valued at 272.34 USD Million in 2024.
- The South Korea Hepatitis B Infection Market is likely to grow at a CAGR of 5.55% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Chronic in Type Segment accounted for the largest share of the market with a revenue of 234.78 USD Million
- The fastest growing segment Online Pharmacies in Distribution Channel Segment grew Fastest with a CAGR of 6.33% during the forecast period from 2024 to 2032.
South Korea Hepatitis B Infection Market Scope
South Korea Hepatitis B Infection Market Segmentation & Scope
Distribution Channel
- Online Pharmacies
- Drugs Stores and Retail Pharmacies
- Hospital Pharmacies
Treatment
- Surgery
- Immune Modulator Drugs
- Antiviral Drugs
- Vaccine
Type
- Acute
- Chronic
South Korea Hepatitis B Infection Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2023 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 272.34 USD Million |
| Market Value in 2032 | 397.57 USD Million |
| CAGR (2025-2032) | 5.55% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,Treatment,Type |
Regional Insights:
-
Leading Market (2024-2032): South Korea, leading in terms of revenue 272.34 USD Million in 2024
- Key Country: South Korea, leading in terms of revenue with value of 272.34 USD Million in 2024.
Segments and Scope
-
South Korea Hepatitis B Infection Market to 2032, By Distribution Channel
- Hospital Pharmacies is the largest segment in South Korea Hepatitis B Infection Market to 2032 with a revenue of 129.05 USD Million in the year 2024.
- Online Pharmacies is the Fastest growing segment in South Korea Hepatitis B Infection Market to 2032 with a Growth rate of 5.02 % in forecast period 2025-2032.
-
South Korea Hepatitis B Infection Market to 2032, By Treatment
- Vaccine is the largest segment in South Korea Hepatitis B Infection Market to 2032 with a revenue of 157.46 USD Million in the year 2024.
- Vaccine is the Fastest growing segment in South Korea Hepatitis B Infection Market to 2032 with a Growth rate of 5.72 % in forecast period 2025-2032.
-
South Korea Hepatitis B Infection Market to 2032, By Type
- Chronic is the largest segment in South Korea Hepatitis B Infection Market to 2032 with a revenue of 234.78 USD Million in the year 2024.
- Chronic is the Fastest growing segment in South Korea Hepatitis B Infection Market to 2032 with a Growth rate of 5.57 % in forecast period 2025-2032.
South Korea Hepatitis B Infection Market Company Share Analysis
| Company Name |
|
||
| Bristol-Myers Squibb Company | |||
| Gilead Sciences, Inc. | |||
| GSK plc | |||
| F. Hoffmann-La Roche Ltd. | |||
| Dynavax Technologies | |||
South Korea Hepatitis B Infection Market Geographical Sales Distribution, 2018-2032 USD Million
South Korea Hepatitis B Infection Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The South Korea Hepatitis B Infection Market is segmented based on Segmentation Distribution Channel,Treatment,Type.
South Korea Hepatitis B Infection Market was valued at USD 272.34(Revenue in USD Million) in 2023.
South Korea Hepatitis B Infection Market is projected to grow at a CAGR of 5.55% during the forecast period of 2024 to 2032.
The Chronic segment is expected to dominate the South Korea Hepatitis B Infection Market, holding a largest market share of 234.78 USD Million in 2024
South Korea Hepatitis B Infection Market Scope
South Korea Hepatitis B Infection Market Segmentation & Scope
Distribution Channel
- Online Pharmacies
- Drugs Stores and Retail Pharmacies
- Hospital Pharmacies
Treatment
- Surgery
- Immune Modulator Drugs
- Antiviral Drugs
- Vaccine
Type
- Acute
- Chronic
Frequently Asked Questions
The South Korea Hepatitis B Infection Market is segmented based on Segmentation Distribution Channel,Treatment,Type.
South Korea Hepatitis B Infection Market was valued at USD 272.34(Revenue in USD Million) in 2023.
South Korea Hepatitis B Infection Market is projected to grow at a CAGR of 5.55% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Hepatitis B Infection Market for final year is USD 397.57 (USD Million).
South Korea Hepatitis B Infection Market Company Profiling
Frequently Asked Questions
The South Korea Hepatitis B Infection Market is segmented based on Segmentation Distribution Channel,Treatment,Type.
South Korea Hepatitis B Infection Market was valued at USD 272.34(Revenue in USD Million) in 2023.
South Korea Hepatitis B Infection Market is projected to grow at a CAGR of 5.55% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Hepatitis B Infection Market for final year is USD 397.57 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.